These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38734226)

  • 1. Efficacy of catheter ablation for ventricular tachycardia in ischemic cardiomyopathy patients without an ICD implantation.
    Li L; Ding L; Wu L; Zheng L; Zhou L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Heart Rhythm; 2024 Nov; 21(11):2148-2156. PubMed ID: 38734226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.
    Di Biase L; Romero J; Du X; Mohanty S; Trivedi C; Della Rocca DG; Patel K; Sanchez J; Yang R; Alviz I; Mohanty P; Gianni C; Tarantino N; Zhang XD; Horton R; Al-Ahmad A; Lakkireddy D; Burkhardt DJ; Chen M; Natale A
    Heart Rhythm; 2021 Jun; 18(6):885-893. PubMed ID: 33592323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.
    Hayashi T; Liang JJ; Muser D; Shirai Y; Enriquez A; Garcia FC; Supple GE; Schaller RD; Frankel DS; Lin D; Nazarian S; Zado ES; Arkles JS; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1530-1539. PubMed ID: 30230120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endo-epicardial vs endocardial-only catheter ablation of ventricular tachycardia: A meta-analysis.
    Cardoso R; Assis FR; D'Avila A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1537-1548. PubMed ID: 31172632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocardial Scar-Homogenization With vs Without Epicardial Ablation in VT Patients With Ischemic Cardiomyopathy.
    Mohanty S; Trivedi C; Di Biase L; Burkhardt JD; Della Rocca DG; Gianni C; MacDonald B; Mayedo A; Shetty SS; Zagrodzky W; Baqai F; Bassiouny M; Gallinghouse GJ; Horton R; Al-Ahmad A; Natale A
    JACC Clin Electrophysiol; 2022 Apr; 8(4):453-461. PubMed ID: 35246406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.
    Žižek D; Mrak M; Jan M; Zupan Mežnar A; Ivanovski M; Žlahtič T; Kajdič N; Antolič B; Klemen L; Skale R; Avramovič Gregorič J; Štublar J; Pernat A; Šinkovec M
    Europace; 2024 May; 26(5):. PubMed ID: 38657209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.
    Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A
    J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate Characterization and Outcomes of Ventricular Tachycardia Ablation in Amyloid Cardiomyopathy: A Multicenter Study.
    Compagnucci P; Dello Russo A; Gasperetti A; Schiavone M; Sehrawat O; Hasegawa K; Mohanty S; Liang JJ; Kapa S; La Fazia VM; Bogun F; Stevenson WG; Tondo C; Siontis KC; Tandri H; Santangeli P; Natale A; Casella M
    Circ Arrhythm Electrophysiol; 2024 Sep; 17(9):e012788. PubMed ID: 39171384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease.
    Izquierdo M; Sánchez-Gómez JM; Ferrero de Loma-Osorio A; Martínez A; Bellver A; Peláez A; Núñez J; Núñez C; Chorro J; Ruiz-Granell R
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):882-9. PubMed ID: 26056239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.
    Maury P; Baratto F; Zeppenfeld K; Klein G; Delacretaz E; Sacher F; Pruvot E; Brigadeau F; Rollin A; Andronache M; Maccabelli G; Gawrysiak M; Brenner R; Forclaz A; Schlaepfer J; Lacroix D; Duparc A; Mondoly P; Bouisset F; Delay M; Hocini M; Derval N; Sadoul N; Magnin-Poull I; Klug D; Haïssaguerre M; Jaïs P; Della Bella P; De Chillou C
    Eur Heart J; 2014 Jun; 35(22):1479-85. PubMed ID: 24536081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up after hemodynamically not tolerated ventricular tachycardia in patients with midrange reduced to normal ejection fraction: A retrospective single-centre case series.
    Groeneveld SA; Blom LJ; van der Heijden JF; Loh P; Hassink RJ
    Eur J Clin Invest; 2021 Jan; 51(1):e13359. PubMed ID: 32705678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review.
    Wissner E; Stevenson WG; Kuck KH
    Eur Heart J; 2012 Jun; 33(12):1440-50. PubMed ID: 22411192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.